Darya-Varia Laboratoria Tbk PT
IDX:DVLA

Watchlist Manager
Darya-Varia Laboratoria Tbk PT Logo
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Watchlist
Price: 1 635 IDR 0.31% Market Closed
Market Cap: 1.8T IDR
Have any thoughts about
Darya-Varia Laboratoria Tbk PT?
Write Note

Intrinsic Value

The intrinsic value of one DVLA stock under the Base Case scenario is 2 178.44 IDR. Compared to the current market price of 1 635 IDR, Darya-Varia Laboratoria Tbk PT is Undervalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DVLA Intrinsic Value
2 178.44 IDR
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Darya-Varia Laboratoria Tbk PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DVLA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DVLA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Darya-Varia Laboratoria Tbk PT

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Darya-Varia Laboratoria Tbk PT

Provide an overview of the primary business activities
of Darya-Varia Laboratoria Tbk PT.

What unique competitive advantages
does Darya-Varia Laboratoria Tbk PT hold over its rivals?

What risks and challenges
does Darya-Varia Laboratoria Tbk PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Darya-Varia Laboratoria Tbk PT.

Provide P/S
for Darya-Varia Laboratoria Tbk PT.

Provide P/E
for Darya-Varia Laboratoria Tbk PT.

Provide P/OCF
for Darya-Varia Laboratoria Tbk PT.

Provide P/FCFE
for Darya-Varia Laboratoria Tbk PT.

Provide P/B
for Darya-Varia Laboratoria Tbk PT.

Provide EV/S
for Darya-Varia Laboratoria Tbk PT.

Provide EV/GP
for Darya-Varia Laboratoria Tbk PT.

Provide EV/EBITDA
for Darya-Varia Laboratoria Tbk PT.

Provide EV/EBIT
for Darya-Varia Laboratoria Tbk PT.

Provide EV/OCF
for Darya-Varia Laboratoria Tbk PT.

Provide EV/FCFF
for Darya-Varia Laboratoria Tbk PT.

Provide EV/IC
for Darya-Varia Laboratoria Tbk PT.

What are the Revenue projections
for Darya-Varia Laboratoria Tbk PT?

How accurate were the past Revenue estimates
for Darya-Varia Laboratoria Tbk PT?

What are the Net Income projections
for Darya-Varia Laboratoria Tbk PT?

How accurate were the past Net Income estimates
for Darya-Varia Laboratoria Tbk PT?

What are the EPS projections
for Darya-Varia Laboratoria Tbk PT?

How accurate were the past EPS estimates
for Darya-Varia Laboratoria Tbk PT?

What are the EBIT projections
for Darya-Varia Laboratoria Tbk PT?

How accurate were the past EBIT estimates
for Darya-Varia Laboratoria Tbk PT?

Compare the revenue forecasts
for Darya-Varia Laboratoria Tbk PT with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Darya-Varia Laboratoria Tbk PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Darya-Varia Laboratoria Tbk PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Darya-Varia Laboratoria Tbk PT compared to its peers.

Compare the P/E ratios
of Darya-Varia Laboratoria Tbk PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Darya-Varia Laboratoria Tbk PT with its peers.

Analyze the financial leverage
of Darya-Varia Laboratoria Tbk PT compared to its main competitors.

Show all profitability ratios
for Darya-Varia Laboratoria Tbk PT.

Provide ROE
for Darya-Varia Laboratoria Tbk PT.

Provide ROA
for Darya-Varia Laboratoria Tbk PT.

Provide ROIC
for Darya-Varia Laboratoria Tbk PT.

Provide ROCE
for Darya-Varia Laboratoria Tbk PT.

Provide Gross Margin
for Darya-Varia Laboratoria Tbk PT.

Provide Operating Margin
for Darya-Varia Laboratoria Tbk PT.

Provide Net Margin
for Darya-Varia Laboratoria Tbk PT.

Provide FCF Margin
for Darya-Varia Laboratoria Tbk PT.

Show all solvency ratios
for Darya-Varia Laboratoria Tbk PT.

Provide D/E Ratio
for Darya-Varia Laboratoria Tbk PT.

Provide D/A Ratio
for Darya-Varia Laboratoria Tbk PT.

Provide Interest Coverage Ratio
for Darya-Varia Laboratoria Tbk PT.

Provide Altman Z-Score Ratio
for Darya-Varia Laboratoria Tbk PT.

Provide Quick Ratio
for Darya-Varia Laboratoria Tbk PT.

Provide Current Ratio
for Darya-Varia Laboratoria Tbk PT.

Provide Cash Ratio
for Darya-Varia Laboratoria Tbk PT.

What is the historical Revenue growth
over the last 5 years for Darya-Varia Laboratoria Tbk PT?

What is the historical Net Income growth
over the last 5 years for Darya-Varia Laboratoria Tbk PT?

What is the current Free Cash Flow
of Darya-Varia Laboratoria Tbk PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Darya-Varia Laboratoria Tbk PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Darya-Varia Laboratoria Tbk PT

Current Assets 1.6T
Cash & Short-Term Investments 437.9B
Receivables 724B
Other Current Assets 455.9B
Non-Current Assets 633.3B
Long-Term Investments 37.9B
PP&E 459.9B
Intangibles 50.2B
Other Non-Current Assets 85.4B
Current Liabilities 610.4B
Accounts Payable 154.1B
Accrued Liabilities 372.3B
Other Current Liabilities 84B
Non-Current Liabilities 163.7B
Long-Term Debt 709.4m
Other Non-Current Liabilities 163B
Efficiency

Earnings Waterfall
Darya-Varia Laboratoria Tbk PT

Revenue
2.1T IDR
Cost of Revenue
-1T IDR
Gross Profit
1.1T IDR
Operating Expenses
-872.2B IDR
Operating Income
252.6B IDR
Other Expenses
-58.7B IDR
Net Income
193.9B IDR

Free Cash Flow Analysis
Darya-Varia Laboratoria Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DVLA Profitability Score
Profitability Due Diligence

Darya-Varia Laboratoria Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 1-Year Revenue Growth
Positive ROE
53/100
Profitability
Score

Darya-Varia Laboratoria Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

DVLA Solvency Score
Solvency Due Diligence

Darya-Varia Laboratoria Tbk PT's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Long-Term Solvency
77/100
Solvency
Score

Darya-Varia Laboratoria Tbk PT's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DVLA Price Targets Summary
Darya-Varia Laboratoria Tbk PT

There are no price targets for DVLA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DVLA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DVLA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Darya-Varia Laboratoria Tbk PT Logo
Darya-Varia Laboratoria Tbk PT

Country

Indonesia

Industry

Pharmaceuticals

Market Cap

1.8T IDR

Dividend Yield

6.61%

Description

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,274 full-time employees. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The firm provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The firm also provides Imunped as supplement for kids with Zinc and vitamin C for children.

Contact

DKI JAKARTA
Jakarta
South Quarter, Tower C, 18th-19th FloorJl. R.A. Kartini Kav.8
+622122768000
www.darya-varia.com

IPO

1994-11-11

Employees

1 274

Officers

Finance Director & Director
Mr. Celso Paz Lim
Head of Legal & Corporate Secretary
Ms. Widya Olivia Tobing
Director of Human Resources Development
Mr. Dandan Darmawan
Director of Manufacturing, Supply Chain, Research & Development and Director
Mr. Angelito Celso Corsame Racho Jr.
Head of Internal Audit Unit
Mr. Chandra Ngesahkan Halomoan Tarigan
Treasury
Mr. Setyo Dumadi

See Also

Discover More
What is the Intrinsic Value of one DVLA stock?

The intrinsic value of one DVLA stock under the Base Case scenario is 2 178.44 IDR.

Is DVLA stock undervalued or overvalued?

Compared to the current market price of 1 635 IDR, Darya-Varia Laboratoria Tbk PT is Undervalued by 25%.

Back to Top